Filter
4391
Filtered Results: 4391
Text search:
drug
strategy
Featured
Recommendations
380
New Publications
1263
Language
Document type
No document type
2739
Studies & Reports
681
Guidelines
505
Manuals
166
Strategic & Response Plan
158
Fact sheets
53
Training Material
45
Situation Updates
22
Infographics
13
Resource Platforms
5
Brochures
2
Dashboards/Maps
1
App
1
Countries / Regions
India
223
Kenya
152
Global
145
Uganda
113
South Africa
112
Ethiopia
108
Western and Central Europe
100
Nigeria
94
Nepal
86
Liberia
82
Zambia
77
Sierra Leone
75
Malawi
74
Tanzania
73
Myanmar / Burma
72
Africa
66
Latin America and the Carribbean
66
Bangladesh
61
Ghana
58
Rwanda
53
Eastern Europe
49
Namibia
44
Ukraine
42
Philippines
41
Indonesia
40
Cambodia
37
Asia
37
Zimbabwe
36
South–East Asia Region
33
Lesotho
31
Botswana
25
Russia
24
Syria
23
Congo, Democratic Republic of
20
Colombia
18
Senegal
17
Mozambique
17
East and Southern Africa
16
Eswatini/ Swaziland
16
Burkina Faso
15
West and Central Africa
15
Brazil
15
Middle East and North Africa
14
South Sudan
13
Eastern Europe and Central Asia
12
Cameroon
11
Albania
11
Tajikistan
10
Thailand
10
USA
10
Venezuela
10
Pakistan
10
Guinea
9
Haiti
9
Sudan
9
Georgia
9
Germany
8
Peru
7
Western Pacific Region
7
Vietnam
7
Benin
6
Laos
6
Afghanistan
6
Argentina
6
Iraq
5
North Macedonia
4
Mexico
4
Turkey
4
China
4
Jordan
4
Southern Africa
4
Lebanon
4
Moldova
4
Sri Lanka
4
Yemen
4
Central African Republic
4
Timor Leste/ East Timor
3
El Salvador
3
Iran
3
Armenia
3
Paraguay
3
Jamaica
3
Bolivia
3
Bhutan
3
Somalia
3
Estonia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Hungary
2
Saudi Arabia
2
North America
2
United Kingdom
2
Portugal
2
Spain
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Honduras
2
Libya
2
Madagascar
2
North Korea
1
Switzerland
1
Serbia
1
Gambia
1
Kazakhstan
1
Chile
1
Canada
1
Fiji
1
Austria
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Nicaragua
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
1792
Clinical Guidelines
384
Public Health
242
Women & Child Health
150
Key Resources
92
Capacity Building
51
Pharmacy & Technologies
44
Annual Report MEDBOX
1
Toolboxes
HIV
553
TB
454
Mental Health
337
AMR
238
COVID-19
168
NTDs
160
Pharmacy
109
NCDs
98
Rapid Response
79
Caregiver
71
Planetary Health
64
Ebola
63
Conflict
52
Global Health Education
48
Disability
47
Refugee
45
Health Financing Toolbox
31
Polio
21
Natural Hazards
17
Specific Hazards
14
Cholera
14
Zika
10
Social Ethics
9
Health Financing
1
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Development finance institutions owned by European governments and the World Bank Group are spending hundreds of millions of dollars on expensive for-profit hospitals in the Global South that block patients from getting care, or bankrupt them, with some even imprisoning patients who cannot afford th...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect ...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Trustworthy, evidence-based health guidelines form the basis of national policies affecting both patients and health-care workers. Emphasizing the link between robust evidence and people’s trust in their health systems, Dr Hans Henri P. Kluge, WHO Regional Director for Europe said at the launch ev...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
This checklist is an operational tool to help national authorities develop or revise national respiratory pathogen (inclusive of influenza and coronaviruses) pandemic preparedness plans.
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
